Financials Opthea Limited

Equities

OPT

AU000000OPT2

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:11 2024-05-03 am EDT 5-day change 1st Jan Change
0.615 AUD +0.82% Intraday chart for Opthea Limited -8.89% +7.89%

Valuation

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 167.1 635.2 468.6 387.4 256.9 407.6 - -
Enterprise Value (EV) 1 145.6 573.5 306.7 322.7 119.9 561.3 619.4 310.4
P/E ratio -4.66 x -23.3 x -6.88 x -2.87 x -1.11 x -1.34 x -1.91 x -5.59 x
Yield - - - - - - - -
Capitalization / Revenue 183 x 786 x 4,981 x 1,343 x 433 x 445 x 23.4 x 2.56 x
EV / Revenue 159 x 709 x 3,260 x 1,119 x 202 x 613 x 35.5 x 1.95 x
EV / EBITDA -4.1 x -23 x -4.46 x -2.31 x -0.52 x -2.27 x -3.17 x 39.1 x
EV / FCF -6.01 x -65.2 x -4.9 x -3.12 x -0.65 x -2.19 x -2.95 x 2.78 x
FCF Yield -16.6% -1.53% -20.4% -32% -155% -45.6% -33.9% 35.9%
Price to Book 3.36 x 6.15 x 2.53 x - -27.1 x -2.52 x -2.5 x 5 x
Nbr of stocks (in thousands) 249,415 269,158 351,004 352,153 467,159 662,809 - -
Reference price 2 0.6700 2.360 1.335 1.100 0.5500 0.6150 0.6150 0.6150
Announcement Date 8/8/19 8/27/20 8/29/21 8/29/22 8/30/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 0.9148 0.8084 0.0941 0.2884 0.5932 0.9162 17.45 159
EBITDA 1 -35.51 -24.92 -68.79 -139.8 -230.9 -247 -195.1 7.929
EBIT 1 -35.55 -25.06 -68.94 -139.9 -231 -267.2 -222.2 -50.1
Operating Margin -3,885.6% -3,100.21% -73,284.21% -48,510.06% -38,939.69% -29,170.83% -1,273.78% -31.51%
Earnings before Tax (EBT) 1 -35.55 -25.06 -68.94 -143.6 -228.6 -291.7 -253.2 -103
Net income 1 -20.91 -16.53 -62.17 -134.5 -219.5 -277.6 -224.5 -47.21
Net margin -2,285.65% -2,044.67% -66,086.21% -46,640.39% -36,991.82% -30,301.57% -1,286.63% -29.7%
EPS 2 -0.1437 -0.1014 -0.1940 -0.3826 -0.4958 -0.4578 -0.3219 -0.1100
Free Cash Flow 1 -24.2 -8.79 -62.59 -103.4 -185.7 -256.2 -209.9 111.6
FCF margin -2,645.62% -1,087.26% -66,532.24% -35,854.05% -31,310% -27,969.62% -1,203.21% 70.16%
FCF Conversion (EBITDA) - - - - - - - 1,406.81%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 8/8/19 8/27/20 8/29/21 8/29/22 8/30/23 - - -
1AUD in Million2AUD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: June 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 0.2731 0.5353 0.3143 -0.1919 - -0.0661 1.914 0.2898 3.082 0.1486
EBITDA -11.51 -13.41 -18.43 - - - - - -141.6 -
EBIT 1 -11.58 -13.48 -38.51 -16.15 -56.24 -83.02 -114 -104.3 -141.7 -163.4
Operating Margin -4,239.37% -2,518.97% -12,251.44% 8,413.07% - 125,676.02% -5,954.51% -35,989.85% -4,597.95% -109,896.59%
Earnings before Tax (EBT) 1 -11.47 -13.6 -38.51 -16.15 - -84.77 -116.1 -106.7 - -150.8
Net income 1 -7.62 -8.909 -34.98 -10.32 - -79.86 -113.1 -100.7 -148.2 -152.5
Net margin -2,789.99% -1,664.38% -11,130.55% 5,375.53% - 120,894.81% -5,908.29% -34,760.84% -4,807.68% -102,607.06%
EPS 2 - - -0.1175 -0.0240 -0.1487 -0.2270 -0.2422 -0.2416 -0.2500 -0.2200
Dividend per Share - - - - - - - - - -
Announcement Date 2/25/20 8/27/20 2/21/21 8/29/21 2/27/22 8/29/22 2/22/23 8/30/23 2/28/24 -
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 154 212 -
Net Cash position 1 21.5 61.8 162 64.7 137 - - 97.3
Leverage (Debt/EBITDA) - - - - - -0.6224 x -1.085 x -
Free Cash Flow 1 -24.2 -8.79 -62.6 -103 -186 -256 -210 112
ROE (net income / shareholders' equity) -60.4% -34.5% -50.4% -101% -677% - - -
ROA (Net income/ Total Assets) -49.9% -34.5% - -93.5% -180% - - -
Assets 1 41.87 47.96 - 143.8 122.2 - - -
Book Value Per Share 2 0.2000 0.3800 0.5300 - -0.0200 -0.2400 -0.2500 0.1200
Cash Flow per Share 2 -0.1700 -0.0500 -0.2000 - -0.4200 -0.3800 -0.2500 0.3100
Capex 1 0.02 0.01 0.02 - 0.03 0.02 0.02 0.01
Capex / Sales 1.98% 0.9% 18.51% - 5.7% 2.46% 0.09% 0.01%
Announcement Date 8/8/19 8/27/20 8/29/21 8/29/22 8/30/23 - - -
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.615 AUD
Average target price
0.8974 AUD
Spread / Average Target
+45.92%
Consensus
  1. Stock Market
  2. Equities
  3. OPT Stock
  4. Financials Opthea Limited